RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RIBALDONE DG
Collezione ASL Città di Torino

Items : 9

Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis. in European journal of clinical investigation / Eur J Clin Invest. 2024 Sep;54(9):e14188. doi: 10.1111/eci.14188. Epub 2024 Feb 23.

2024
ASL Città di Torino
AOU Città della Salute di Torino

De Ferrari GM; D'Ascenzo F; Iannaccone M; Bugianesi E; Mennini G; Corradini SG; Mancone M; Zullino V; Bruno F; Gallone G; Armandi A; Birtolo LI; Nebiolo M; Gatti M; Ribaldone DG; De Filippo O; Di Pietro G;

Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease. in Journal of clinical medicine / J Clin Med. 2024 Nov 29;13(23):7277. doi: 10.3390/jcm13237277.

2024
ASL Città di Torino

Fe P; Bottari A; Costa F; Ceccarelli L; Armandi A; Caviglia GP; Antonucci M; Infusino V; D Avolio A; Ribaldone DG; Cusato J; Bertani L; De Vita F;

Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease. in Biomedicines / Biomedicines. 2024 Jan 30;12(2):320. doi: 10.3390/biomedicines12020320.

2024
ASL Città di Torino
AOU Città della Salute di Torino

Ribaldone DG; D'Avolio A; Saracco GM; Armandi A; Caviglia GP; Vernero M; Manca A; Palermiti A; Antonucci M; Cafasso C; Cusato J;

Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. in Biomedicines / Biomedicines. 2024 Apr 9;12(4):824. doi: 10.3390/biomedicines12040824.

2024
ASL Città di Torino

Caviglia GP; D'Avolio A; Fornaroli G; Bottari A; Costa F; Ceccarelli L; Saracco GM; Palermiti A; Antonucci M; Manca A; Falzone MH; Ribaldone DG; Cusato J; Bertani L;

Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. in International journal of cardiology / Int J Cardiol. 2023 May 1;378:96-104. doi: 10.1016/j.ijcard.2023.02.042. Epub 2023 Mar 1.

2023
ASL Città di Torino
AOU Città della Salute di Torino

Ribaldone DG; Bugianesi E; Armandi A; De Ferrari GM; Bernstein CN; Caviglia GP; Giannino G; Testa G; De Filippo O; Bruno F; Iannaccone M; D'Ascenzo F;

Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Nov 27;14(12):1230. doi: 10.3390/ph14121230.

2021
ASL Città di Torino

Ribaldone DG; Zanzi F; Astegiano M; Ceccarelli L; Costa F; Mula J; Massano A; Mangia M; Dibitetto S; Caviglia GP; Tomasello C; Bertani L; Antonucci M; D'Avolio A; Cusato J;

Risk of drug interactions and prescription appropriateness in elderly patients. in Irish journal of medical science / Ir J Med Sci. 2020 Aug;189(3):953-959. doi: 10.1007/s11845-019-02148-8. Epub 2019 Nov 30.

2020
ASL Città di Torino

Petrini E; Caviglia GP; Pellicano R; Saracco GM; Morino M; Ribaldone DG;

Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients. in Journal of clinical medicine / J Clin Med. 2019 Feb 6;8(2):199. doi: 10.3390/jcm8020199.

2019
ASL Città di Torino

Ribaldone DG; Fagoonee S; Astegiano M; Durazzo M; Morgando A; Sprujevnik T; Giordanino C; Baronio M; De Angelis C; Saracco GM; Pellicano R;

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.

2019
ASL Città di Torino
AOU Città della Salute di Torino

Luzza F; D'Avolio A; Perri GD; Canaparo R; Pellicano R; Riganò D; Simiele M; Agnesod D; Nicolò A; Caviglia GP; Adriani A; Ribaldone DG; Saracco GM; Astegiano M;